Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis
- PMID: 35019898
- DOI: 10.1097/TP.0000000000004033
Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis
Abstract
Background: Kidney biopsy is important to guide the management of allograft dysfunction but has a risk of complications. This review aimed to determine the incidence and risk factors of complications after kidney allograft biopsy.
Methods: This is a systematic review and meta-analysis of randomized controlled trials, cohort studies, or case-control studies indexed on PubMed, Embase, Cochrane Central Register of Controlled Trials, World Health Organization International Clinical Trials Registry, and ClinicalTrials.gov, limited to the English language, from January 2000 to December 2020, including adult and pediatric kidney allograft biopsies. Primary outcomes were gross hematuria, bleeding requiring transfusion, and major complications (requiring interventions such as blood transfusion or surgical or radiological interventions).
Results: The review included 72 studies (40 082 biopsies). The quality of included studies was suboptimal. Pooled rates of gross hematuria, bleeding requiring transfusion, and major complications were 3.18% [95% confidence interval (95% CI), 2.31-4.19], 0.31% (95% CI, 0.15-0.52) and 0.89% (95% CI, 0.61-1.22), respectively. Gross hematuria rates were lower in high-income compared with middle-income countries (2.59% versus 6.44%, P < 0.01) and biopsies performed by radiology as compared with nephrology departments (1.25% versus 3.71%, P < 0.01). Blood transfusion rates were lower in pediatrics than adults (0.0% versus 0.65%, P < 0.01). Major complications were lower in biopsies performed by specialists as compared with trainees (0.02% versus 3.64%, P < 0.01). Graft loss and mortality were extremely rare. Limitations included missing data, few randomized controlled trials, and possible publication bias.
Conclusions: The risk of complications after kidney allograft biopsy was low. Given the low quality of included studies, risk factors for complications should be further examined in future studies.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no funding or conflicts of interest.
References
-
- Williams WW, Taheri D, Tolkoff-Rubin N, et al. Clinical role of the renal transplant biopsy. Nat Rev Nephrol. 2012;8:110–121.
-
- Redfield RR, McCune KR, Rao A, et al. Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy. Transpl Int. 2016;29:167–172.
-
- Whittier WL, Gashti C, Saltzberg S, et al. Comparison of native and transplant kidney biopsies: diagnostic yield and complications. Clin Kidney J. 2018;11:616–622.
-
- Simard-Meilleur MC, Troyanov S, Roy L, et al. Risk factors and timing of native kidney biopsy complications. Nephron Extra. 2014;4:42–49.
-
- Maya ID, Allon M. Percutaneous renal biopsy: outpatient observation without hospitalization is safe. Semin Dial. 2009;22:458–461.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical